Skip to content

Study on the correlation between inflammatory markers and sarcopenia development in elderly patients with acute infection under comprehensive intervention

Study on the correlation between inflammatory markers and sarcopenia development in elderly patients with acute infection under comprehensive intervention

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600126078
Enrollment
Unknown
Registered
2026-06-03
Start date
2025-10-01
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sarcopenia

Interventions

Group 1:Anti-inflammatory diet combined with exercise intervention,
Group 2:High-protein diet combined with exercise intervention
Group 3:Pure exercise intervention,
Group 4:Pure anti-inflammatory diet intervention

Sponsors

Huadong Hospital affiliated to Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Shanghai elderly population aged 60 years or older; 2. Individuals capable of completing the full screening process for sarcopenia diagnostic criteria; 3. Patients hospitalized due to acute onset with elevated inflammatory markers; 4. (1) No physical limitations or memory/cognitive impairment; (2) No severe chronic liver or kidney disease; (3) No active rheumatic or autoimmune diseases; (4) No urinary tract stones; (5) No history of malignant tumors; (6) No other chronic conditions affecting bone and muscle metabolism; (7) Not currently using glucocorticoids; (8) Not taking any other medications that affect bone and muscle metabolism; (9) No severe chronic liver or gallbladder system diseases.

Exclusion criteria

Exclusion criteria: 1.Patients who refused to undergo sarcopenia screening; 2. Patients who were unable to communicate or whose existing clinical data could not provide valid information to assess their condition; 3.Patients who declined to participate in the study or had incomplete clinical data; 4.Patients who could not undergo regular follow-up.

Design outcomes

Primary

MeasureTime frame
Routine blood test;

Secondary

MeasureTime frame
Inflammatory factors;

Countries

China

Contacts

Public ContactBao Zhijun

East China Hospital affiliated to Fudan University

zhijunbao@fudan.edu.cn+86 139 1713 6990

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026